fbpx

Författare: johan@emergers.se

AGTIRA: Lidl deal solid stepping stone for Agtira towards FaaS-profitability

Analys, Research

With the fresh 10-year deal to supply Lidl from a new 10,000 sqm production facility in a FaaS-setup, Agtira is now about to get all the...

Read More

GRANGEX: Anglo American deal marks crucial step in transforming GRANGEX into leader in sustainable iron ore

Analys, Research

GRÄNGESBERG EXPLORATION Hours before the Christmas weekend, GRANGEX announced a Royalty and off-take agreement with Anglo American of USD...

Read More

NANEXA: Lining up to make Nanexa (close to) a pure GLP-1 play

Analys, Research

Following the focusing of the roadmap after the rights issue in October, Nanexa has now announced a further streamlining of its activities...

Read More

QLUCORE: Long term potential clouded by likely capital raise

Analys, Research

With stable sales in H1’23/24, Qlucore has continued on the revised, more concentrated path announced in Q1, accompanied by a cost...

Read More

GRANGEX: Pushing ahead with dual mines in the face of double delays

Analys, Research

GRÄNGESBERG EXPLORATION Facing delays in both financing and operational development, the current cash at SEK 43.6m means that GRANGEX must...

Read More

NANEXA: Raising our LOAs following a review of the projects

Analys, Research

With the dust settling after the recent rights issue, Nanexa now progresses with its more focused roadmap, concentrating on Phase I trials...

Read More

NANEXA: Outcome of rights issue forces an investor-friendly focus on core projects

Analys, Research

With a subscription rate of 34.7% of the rights issue, and a utilization of guarantee commitments corresponding to 27.1%, Nanexa is...

Read More

KEBNI: Mixed bag in Q3 – steep growth ahead

Analys, Research

Despite 29% top-line growth in Q3’23, sales were a bit soft due to a slower-than-anticipated ramp-up of deliveries to Saab. This has led...

Read More

KEBNI: Site visit provided clarity on scale-up and insight into ScaffSense venture

Analys, Research

Our site visit to KebNi’s new production facility in Karlskoga not only showed production up and running, but also how it can scale...

Read More

NANEXA: Variable roadmap with emphasis on NEX-22 and potential Novo Nordisk deal

Analys, Research

With the recently completed Phase 1 study for NEX-20 yielding positive results, and the widespread global interest in GLP-1, Nanexa now has...

Read More

For new research on growth stocks, sign up to our newsletter